East Haven, CT, United States of America

Zhe-Quing Wang

This inventor holds 2 USPTO granted patents. Top assignees: Neurogen Corporation, Pfizer Corporation. Active years: 2003-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhe-Quing Wang. Retrieved from https://idiyas.com/inventor/zhe-quing-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 103(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zhe-Quing Wang: Innovator in Heterocyclic Compounds

Introduction

Zhe-Quing Wang is a notable inventor based in East Haven, CT (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of heterocyclic compounds.

Latest Patents

Zhe-Quing Wang holds 2 patents. His latest patents include innovations related to heterocyclic compounds as ligands of the GABAA receptor. These patents disclose compounds that are highly selective agonists, antagonists, or inverse agonists for GABA brain receptors, as well as prodrugs of these compounds.

Career Highlights

Throughout his career, Zhe-Quing Wang has worked with prominent companies such as Neurogen Corporation and Pfizer Corporation. His work has contributed to advancements in pharmacology and therapeutic applications.

Collaborations

Zhe-Quing Wang has collaborated with notable individuals in his field, including Daniel Yohannes and George D. Maynard. These collaborations have further enhanced his research and development efforts.

Conclusion

Zhe-Quing Wang's innovative work in the field of heterocyclic compounds has positioned him as a key figure in medicinal chemistry. His contributions continue to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…